Skip to content
HomeLatest newsInnovationDoseBiome: The start-up that’s on a mission to make better oral care as simple as sipping tea
A woman drinking qii tea

DoseBiome: The start-up that’s on a mission to make better oral care as simple as sipping tea

In honor of World Oral Health Day, check out this enterprising company focused on helping supplement regular dental care with an innovative drink.

Share Article
share to

One of the most exciting areas of healthcare research in recent years has been focused on the human microbiome— the collective term for the trillions of microorganisms that inhabit our bodies.

And that research knows no bounds, from leveraging knowledge about the gut microbiome to help inform treatments for digestive disorders to harnessing the microbiome that lives on the surface of your skin to help treat things like eczema.

Another area of microbiome research packed with potential? The mouth. And DoseBiome is one of the companies at the forefront of this work.

Ted Jin, founder and CEO of DoseBiome

Ted Jin, founder and CEO, DoseBiome

The company launched in 2016 and was accepted as one of 50 resident companies working at JLABS @ Toronto—a Johnson & Johnson Innovation incubator aimed at helping nurture healthcare start-ups—that summer. Since then, DoseBiome has launched its flagship consumer product, a first-of-its-kind packaged beverage called qii that the company’s research shows may help shield your pearly whites from cavities by helping to balance your oral microbiome.

For the first installment in our new Start-Up Success Story series, in which we highlight young companies that have made great strides with help from their residencies at JLABS, we sat down with DoseBiome founder and CEO Ted Jin to get the inside scoop on what it takes to be a player in the microbiome field.

The aha! moment

Three and a half years ago, Jin was working as an executive within the oral care division of a healthcare company and feeling restless. “I wanted to focus on innovation,” Jin recalls. “Although it’s risky to strike out on your own, there’s the potential to leap forward not just by inches, but by miles—and that really appealed to me.”

Inspired by the research boom around the microbiome, Jin grew curious about the role bacteria played when it came to halitosis, cavities, gingivitis and periodontal disease. Could balancing our oral microbiome help keep our teeth and gums in good condition?

In May 2016, with those questions in mind, he launched DoseBiome. Total employees: 1—himself.

It occurred to Jin that most people have a well-established pattern of brushing in the morning and before bed, but they rarely pay attention to their teeth in the middle of the day—which is also when they’re likely to indulge in sugary snacks and drinks. “I wanted to find an alternative that was not only tasty but something that might actually help improve oral health,” Jin says.

He then took the idea one step further: What if he could create a beverage designed to balance the oral microbiome? Based on existing research, he knew that xylitol, a plant-based, zero-calorie sugar substitute, had been shown to help inhibit the formation of plaque, a sticky substance that can lead to tooth decay and gum disease. The caveat, according to Jin, is that xylitol generally doesn’t stick around in your mouth long enough to have a positive effect—as soon as you swallow, it’s gone.

“So my first goal was to develop a new composition that would increase the effectiveness of xylitol in the mouth, giving it a greater chance to counter harmful bacteria,” Jin explains.

There was just one problem: Microbiology research requires a good deal of specialized lab equipment, and the scrappy start-up was short on capital. “If I’d had to start my own lab, I would have been dead in the water,” Jin says. “The cost would have been too much of a burden.”

JLABS helped us cut through a lot of the early, time-consuming work of setting up a company. As a result, we were able to jump straight into innovation.

Getting a JLABS boost early on

As fate would have it, Jin caught wind of the JLABS @ Toronto facility, which offered emerging healthcare entrepreneurs lab space, equipment, mentorship and access to investors. DoseBiome applied and was awarded a residency—and was able to quickly add employees who could help dive into research and development.

“JLABS helped us cut through a lot of the early, time-consuming work of setting up a company by advising us on issues large and small—from handling waste disposal and equipment maintenance to sourcing reliable lab equipment suppliers and manufacturers,” Jin says. “As a result, instead of spending months on administrative stuff, we were able to jump straight into innovation.”

And jump they did: Within six months, the team had grown to seven people, and they had fine-tuned a xylitol composition that they dubbed XyVita.

Ted Jin with the DoseBiome team

Jin (center left) with the DoseBiome team

The next challenge was product development: What was the best way to concoct a tasty beverage based on their formulation? The team eventually landed on tea, and the reason was twofold. First, it’s fairly pH neutral, which the company’s research indicates may help maintain a healthy mouth by keeping acid and disease-causing microbes at bay. It’s also an oral powerhouse: Studies show tea can help inhibit cavities, banish bad breath and prevent gum disease.

Over the next year, DoseBiome sourced its own tea leaves from a small farm in Taiwan; developed a brewing process to optimize the tea’s oral health-boosting extracts via precise water temperatures and steeping time; and designed specialized packaging to maintain the drink’s nutrient content and pH level.

In January 2018, DoseBiome introduced qii, an oral health drink that removes up to 52% of plaque in one serving, according to studies conducted by the company. Fun fact: qii (pronounced chee) is how you say “seven” in Mandarin, which is the pH level of qii and also the pH level of saliva that usually indicates good dental health.

With qii’s release, DoseBiome is now among the 26% of JLABS incubatees that currently have a product on the market.

“I admire how quickly DoseBiome has been able to commercialize its product,” says Stefanie Dhanda, Senior Director, Scientific Innovation, Johnson & Johnson Consumer, and DoseBiome’s primary mentor. “Its lean team makes things happen quickly, and their robust approach to product development from the get-go will help them scale going forward.”

And speaking of scaling up, JLABS has also helped DoseBiome secure crucial seed capital. Like many fledgling entrepreneurs, Jin had struggled to even land meetings prior to joining JLABS. “Now, as soon as we say we’re with JLABS, investors perk up,” Jin says. To date, Jin’s company has raised $4.3 million from such investors as Horizon Ventures.

The JLABS staff also hooked up DoseBiome with trusted external consultants, including an oral care regulatory expert.

“As mentors, we often see that start-ups aren’t familiar with the level of regulatory and clinical work required by large healthcare companies to make product claims, but Ted realized this early on through his previous role,” Dhanda says. “By having his team engage with our experts, they were able to incorporate insights into their work plan and validate their development approach, which will ultimately lead to high quality data that will be well-received by investors or acquirers down the road.”

From pipe dream to store shelves across the country
Today, qii is stocked in hundreds of natural and specialty grocery stores in 50 states, with new locations added every day. It’s also available via Amazon and the company’s website.

Two cans of qii tea

The drink comes in five flavors, all made by pairing organic, fair-trade tea with natural extracts: Lemongrass Ginger, Lychee, Oolong, Pomegranate and White Peach.

Feedback has been positive, says Jin, with customers particularly enjoying the drink’s tea-forward taste and the fact that it uses all natural ingredients.

“It’s gratifying and exciting to see qii in the hands of regular people,” Jin adds. “Every day, we get a report listing new stores that are carrying the product, which is so exciting. That euphoria serves as inspiration to do this all over again.”

And speaking of doing it again ...

The company is already sinking its teeth into developing a new product, with a pipeline stretching all the way out to 2021. “The heavy lifting was in the first two years, and now we’re building on our existing knowledge base and platform,” Jin says. “We’re working on an innovation drumbeat, where every 12 months we have something new coming out.”
And, according to Dhanda, the company’s progress is sure to serve as inspiration for more research and innovation around the oral microbiome. “DoseBiome is helping to seed a new market of functional products for oral care that’s delivered in unique ways,” she says.

Now that’s something to smile about.

The JLABS 2018 Impact Report

Did you know that JLABS companies have secured $11.6 billion in financing this year alone? Read on to see how JLABS supports over 450 companies worldwide.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.